Quote:
Originally Posted by blueash
Once again you are wrong. Whatever sources you are using are wrong. The mRNA vaccines have been shown to induce both B cell and T cell immunity.
What do the authors advise?
“We demonstrate reduced T-cell responses in vaccinated individuals to SARS-CoV-2 variants of concern,” writes Maus and colleagues.
The researchers say the decrease in T-cell response to the variants was smaller than has been observed in antibody neutralization assays.
“However, it will be important to determine how T-cell immunity impacts aggregate immune response to the variant SARS-CoV-2 viruses and if this reduction translates to adverse clinical outcomes,” concludes the team.
Pfizer/BioNTech and Moderna vaccines induce T-cell immunity against SARS-CoV-2).
Do you see that? The vaccine induced a more vigorous T cell response than having the disease produced? Of course it was Harvard and MIT so it is all part of the conspiracy of institutions of higher education in that liberal state of Massachusetts. You might not believe what they report.
Maybe you would believe a report from 2020 in the journal Nature from British researchers who reported about the AZ vaccine
You again are wrong and spreading dangerous misinformation. By the way, Dr. Malone certainly is not the inventor of mRNA vaccines. He was a participant, not the leader, in some studies in the 1990's on mRNA. He never produced a vaccine. The person credited with in fact doing the heavy lifting in promoting use of mRNA is Katalin Kariko. The only "authority" who credits Dr. Malone, is Dr. Malone on his own website. You can read his opinions on Epoch Times where he is a featured person. So Harvard, MIT, the journal Nature vs Epoch Times.
You still have not answered my query as to what kind of doctor drducat might be. Maybe one of the alternative fields? Maybe not even any training in medicine.. like Dr Dre or Dr J? |
Did you miss something??
What do the authors advise?
“We demonstrate reduced T-cell responses in vaccinated individuals to SARS-CoV-2 variants of concern,” writes Maus and colleagues.
The researchers say the decrease in T-cell response to the variants was smaller than has been observed in antibody neutralization assays.
“However, it will be important to determine how T-cell immunity impacts aggregate immune response to the variant SARS-CoV-2 viruses and if this reduction translates to adverse clinical outcomes,” concludes the team.
*Important Notice
bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.